Comparing pain relief methods during medical abortion
Official title: Effectiveness of Proactive Versus On-Demand Pain Relief With Non-Steroidal Anti-Inflammatory Drugs During Medical Abortion at 13 to 22 Weeks at Hung Vuong Hospital
Run by Hung Vuong Hospital · NCT06696573 · Data updated 2026-11-12
This study is testing whether taking pain relief medication before a medical abortion helps women feel less pain compared to taking it only when they need it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 180 (estimated) |
| Sponsor | Hung Vuong Hospital Academic / other |
| Locations | 1 site (Ho Chi Minh City) |
| Status | Recruiting |
| Started | December 13, 2024 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | March 13, 2025 |
| Trial ID | NCT06696573 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18 and older, between 13 and 22 weeks of gestation, who are seeking a medical abortion.
✕Probably not a fit
Patients with contraindications to medical abortion or those with certain medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) for pain management during medical abortion procedures for pregnancies between 13 and 22 weeks. Participants will be divided into two groups: one receiving NSAIDs prophylactically and the other receiving them on-demand as pain occurs. The study aims to determine if the prophylactic approach leads to better pain relief outcomes and to assess any potential adverse effects associated with NSAID use in this context. Pain levels will be monitored using validated scales throughout the procedure.
Why it matters
Potential benefit: If successful, this study could provide a more effective pain management strategy for women undergoing medical abortion.
How similar studies have gone: Previous studies have shown varying success with NSAIDs in pain management, but this specific approach in the context of medical abortion is less explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women aged 18 years or older. * No mental illness. * Gestational age between 13 and 22 weeks (based on the last menstrual period with a regular menstrual cycle and accurate recall of the last menstrual period, or based on a first-trimester ultrasound) with an indication of stillbirth, fetal malformation requiring termination, or voluntary abortion with counseling and understanding of the abortion procedure. * Willing to participate in the study. * Capable of reading and signing the informed consent form. * Able to provide personal information independently. Exclusion Criteria: * Medical conditions contraindicating medical abortion: bleeding disorders, anticoagulant use, moderate to severe anemia. * Cardiovascular conditions: heart failure, mitral valve stenosis, embolism, uncontrolled hypertension. * Other medical conditions: renal failure, adrenal gland disorders, severe asthma, liver and biliary diseases, glaucoma. * Active pelvic inflammatory disease or acute genital infections. * Previous uterine surgery. * Placenta previa or central placenta previa. * Uterine malformations. * History of allergy to NSAIDs, Mifepristone, or Misoprostol. * Unwillingness to participate in the study.
Where it's running
-
Hung Vuong Hospital
Ho Chi Minh City, Vietnam Recruiting
Study contacts
- Study coordinator: Le Trang, MD
- Email: lethikieutrang912@gmail.com
- Phone: +8434615919
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexmedetomidine as add-on for refractory cancer pain in palliative care
This study tests whether adding dexmedetomidine helps improve pain control for adults with cancer in palliative care whose pain remains high despite opioids.
-
Two Ways to Help Pain After Breast Surgery: Education-Based Analgesia vs Standard Care
This trial tests whether teaching patients about pain management and using a multimodal pain plan improves pain control and recovery after breast surgery compared with standard care.
-
Virtual Reality Therapy to Improve Arthroplasty Outcomes
This pilot test checks whether using virtual reality during the perioperative period helps knee or hip replacement patients feel better about their care and recover more easily.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Analgesic effects of adding BiFeS block to adductor canal block after ACL reconstruction
This study tests whether adding a BiFeS block to the standard adductor canal block provides better pain relief after ACL reconstruction.
-
Tegileridine for pain after bariatric surgery
This phase 3 trial tests tegileridine vs standard opioid medicine to see if it provides good pain relief after bariatric surgery while considering sleep apnea status.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.